Drug & intervention
empagliflozin / linagliptin / metformin Extended Release Oral Tablet [Trijardy]
RxCUI 2359282
What this record represents
SBDF · RxNormThis is an RxNorm SBDF drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
TrijardyBN · CureCurrent ID 70715
empagliflozin 10 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG [Trijardy]SBDC · CureCurrent ID 70716
empagliflozin 25 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG [Trijardy]SBDC · CureCurrent ID 70738
empagliflozin 5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG [Trijardy]SBDC · CureCurrent ID 70741
empagliflozin 12.5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG [Trijardy]SBDC · CureCurrent ID 70720
24 HR empagliflozin 10 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Trijardy]SBD · CureCurrent ID 70718
24 HR empagliflozin 25 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Trijardy]SBD · CureCurrent ID 70739
24 HR empagliflozin 5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Trijardy]SBD · CureCurrent ID 70742
24 HR empagliflozin 12.5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Trijardy]SBD · CureCurrent ID 70721
Advertisement
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.